Submit your email to push it up the queue
Crucell Switzerland AG, a prominent player in the biopharmaceutical industry, is headquartered in CH and operates extensively across Europe and beyond. Founded in 2000, the company has made significant strides in vaccine development and biopharmaceutical production, focusing on innovative solutions for infectious diseases. Crucell is renowned for its unique technologies, including the PER.C6® cell line, which enhances the efficiency and safety of vaccine production. This proprietary platform has positioned Crucell as a leader in the market, contributing to notable achievements in public health initiatives. With a commitment to advancing healthcare, Crucell Switzerland AG continues to play a vital role in the global fight against infectious diseases, solidifying its reputation as a trusted name in the biopharmaceutical sector.
How does Crucell Switzerland AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Crucell Switzerland AG's score of 81 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Crucell Switzerland AG, headquartered in CH, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Johnson & Johnson, which means its climate commitments and initiatives are influenced by its parent organisation. Crucell Switzerland AG inherits its climate targets and performance metrics from Johnson & Johnson, which has established various sustainability initiatives. These include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all at a cascade level of 2. However, specific reduction targets or achievements for Crucell Switzerland AG are not detailed in the available data. As part of its corporate family, Crucell is aligned with Johnson & Johnson's broader climate strategy, which aims to reduce greenhouse gas emissions across its operations. While no specific emissions data is available for Crucell Switzerland AG, the company's commitment to sustainability is evident through its association with these industry-standard initiatives.
Access structured emissions data, company-specific emission factors, and source documents
1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Crucell Switzerland AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.